Tubuloglomerular feedback, prostaglandins, and angiotensin in the autoregulation of glomerular filtration rate  by Schnermann, Jürgen et al.
Kidney International, Vol. 25 (1984), pp. 53—64
Tubuloglomerular feedback, prostaglandins, and angiotensin in
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Tubuloglomerular feedback, prostaglandins, and angiotensin in the
autoregulation of glomerular filtration rate. To define the mechanisms
responsible for autoregulation of SNGFR in the subnormal pressure
range, the response of SNGFR to graded reductions of arterial pressure
was measured before and after interfering with the tubuloglomerular
feedback system (TGF), angiotensin II action and prostaglandin (PG)
synthesis. Studies were performed in male Sprague-Dawley rats in
which estimated surgical plasma losses were replaced, because euvole-
mic animals were found to have better autoregulatory capacity than
hydropenic animals. In control plasma-replaced animals, a pressure
reduction from normal to 97.5 mm Hg and a further reduction to 78 mm
Hg had no significant effect on SNGFR (31.8 1.32 to 31.7 1.6 to
29.3 1.48 nI/mm) when all autoregulatory mechanisms were intact.
After eliminating TGF, the same pressure steps were followed by
significant reductions in SNGFR (40.8 1.75 to 36,4 2.18 to 31.0
1.56 nI/mm). During infusion of saralasin (I sg/kg mm), SNGFR did
not change significantly during reduction of pressure from normal to
95.5 mm Hg (32.0 1.02 to 30.7 1.58 nI/mm) but fell when pressure
was reduced to 77mm Hg (26.0 1.19 nl/min). Infusion of this dose of
saralasin was without significant effect on the response of early
proximal flow rate to loop of Henle perfusion. During indomethacin-
induced inhibition of PG synthesis, SNGFR fell significantly in re-
sponse to both pressure steps (38.6 1.4 to 34.0 1.68 to 25.5 1.29
nI/mm). An analysis of the autoregulatory components indicates that in
the higher pressure interval 115 to 95 mm Hg, TGF contributes about
50% and PG's about 30% to autoregulatory adjustments. In the lower
pressure interval, 95 to 78 mm Hg, 30% autoregulatory compensation
occurs through the TGF mechanism and 20% depends upon the action
of angiotensin II. Probably in part by interfering with both of these
mechanisms, inhibition of PG synthesis reduces autoregulatory com-
pensation by about 60%.
Rétrocontrole tubulo-glomérulaire, prostaglandines, et angiotensine
dans l'autorégulation de le debit de filtration glomerulaire. Afin de
définir les mécanismes responsables de l'autorégulation de SNGFR
dans des limites de pressions subnormales, la réponse de SNGFR a des
reductions progressives de Ia pression artérielle a été mesurée avant et
après une interference sur le système de rétrocontrôle tubulo-glomeru-
laire (TGF), sur l'action de l'angiotensine II, et sur La synthèse de
prostaglandine (PG). Les etudes ont èté effectuées sur des rats males
Sprague-Dawley, chez lesquels les pertes plasmatiques chirurgicales
estimées étaient remplacées, car il a été trouvé que les animaux
normaux volemiques ont une meilleure capacité d'autoregulation que
les animaux hydropéniques. Chez les animaux contrôles, avec rempla-
cement plasmatique, une reduction de pression de Ia normale a 97,5 mm
Hg puis une reduction supplementaire a 78 mm Hg n'avaient pas d'effet
significatif sur SNGFR (31,8 1,32 31,7 1,6 a 29,3 1,48 nI/mm),
lorsque tous les mécanismes autoregulateurs étaient intacts. Après
elimination de TGF, les mèmes niveaux de pression étaient suivis de
reductions significatives de SNGFR (40,8 1,75 a 36,4 2,18 a 31,0
1,56 nI/mm). Pendant une perfusion de saralasine (I sg/kg mm)
SNGFR ne s'est pas modifiée significativement pendant la reduction de
pression de Ia normale a 95,5 mm Hg (32,0 1,02a 30,7 1,58 nI/mm),
mais a chute lorsque Ia pression a étè réduite a 77mm Hg (26,0 1,19
nllmin). La perfusion de cette dose de saralasine était sans effet
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significatif sur Ia réponse du debit proximal précoce vers Ia perfusion de
l'anse de Henle. Pendant une inhibition de Ia synthèse de PG induite par
l'indomèthacine, SNGFR a diminué significativement en reponse aux
deux niveaux de pression (38,6 1,4 a 34,0 1,68 a 25,5 1,29
nI/mm). Une analyse des constituants de l'autoregulation mndique que
dans l'intervalle de pression le plus élevè, de 115 a 95 mm Hg, TGF
contribue pour environ 50%, et les prostaglandines pour 30% des
ajustements autoregulateurs. Dans l'intervalle de pression le plus faible,
95 a 78 mm Hg, 30% de Ia compensation autoregulatrice se produit
grace au mécanisme de TGF, et 20% dependent de l'action de l'angio-
tensine II. Probablement, en interférant en partie avec chacun de ces
mécanismes, l'inhibition de Ia synthèse de PG réduit Ia compensation
autoregulatrice d'environ 60%.
Alterations in arterial pressure are followed by rapid adjust-
ments in renal resistance that, over a certain pressure range,
result in rather precise maintenance of RBF and filtration rate.
Evidence has accumulated to suggest that in the kidney auto-
regulation is achieved by the combined effect of several control
systems. Although a contrary report exists [1], a number of
studies have demonstrated that constancy of SNGFR in the
face of altered arterial pressure depends on intact flow to the
distal nephron [2—5]. This finding implicates the tubuloglomer-
ular feedback mechanism which couples tubular flow rate and
GFR as contributing to autoregulation. On the other hand,
changes in transmural pressure produce a vasomotor response
in the glomerular microvasculature of renal tissue transplanted
to the hamster cheek pouch, demonstrating inherent myogenic
capacity for pressure-induced resistance changes independent
of an intact tubular system [6]. In a recent attempt to quantify
the role of different control systems, we found that in the supra-
normal pressure range blockade of the tubuloglomerular feed-
back mechanism reduced the effectiveness with which SNGFR
was autoregulated by approximately 50% but did not abolish
autoregulation [5]. Consequently, a residual mechanism or
mechanisms was needed to explain the balance of the autoregu-
latory resistance changes. Recent studies of Young and Marsh
[7] suggest that two mechanisms are also needed to explain
autoregulation of RBF. They concluded, based on an analysis
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of the time-course of autoregulatory resistance changes in
response to an abrupt change in arterial pressure, that the
vascular response was biphasic and that approximately half the
resistance change occurred before distal tubular flow was
perturbed, but the remaining resistance changes occurred with
a time course compatible with the known pattern of response of
the tubuloglomerular feedback mechanism [8].
The present studies were performed to evaluate the mecha-
nisms contributing to autoregulation of the filtration rate when
arterial pressure is reduced below normal. There are reasons to
expect quantitative and qualitative differences between the
subnormal and supranormal pressure ranges in the importance
of compensatory mechanisms. Several lines of evidence suggest
that the tubuloglomerular feedback mechanism may have a
vasodilatatory capacity that is less than its vasoconstrictor
potential [9, 10]. This could restrict its participation in the
subnormal pressure range. On the other hand, the contribution
of vasoactive intrarenal hormones might possibly be greater in
this pressure interval. For example, studies in the dog indicate
that angiotensin contributes importantly to maintaining filtra-
tion rate in the face of reduced arterial pressure [11, 12], but it is
probably a factor of minor importance at elevated pressures. In
the present studies we attempted to evaluate the effectiveness
of the autoregulation of filtration rate in the subnormal pressure
range in the rat in control conditions and during interference
with three potential autoregulatory mechanisms, the tubulo-
glomerular feedback response, the formation of prostaglandins,
and the renin-angiotensin system.
Methods
Experiments were performed on male Sprague-Dawley rats
ranging in weight from 174 to 310 g. Rats were anesthetized by
intraperitoneal injection of mactin (110 mg/kg) and placed on a
heated operating table. Catheters were inserted into the femoral
artery and the jugular vein for infusion of saline at a rate of 1.2
mi/hr for rats weighing more than 200 g and 0.9 ml/hr for rats
weighing 200 g or less. 3H-inulin (NEN) was added to the
infusion to yield an infusion rate of 200 SC/hr. The left kidney
was exposed from a flank incision, freed of surrounding tissue,
placed in a holder (Lucite®) and superfused with warm mineral
oil. We placed an adjustable clamp around the aorta above the
renal arteries exercising care to avoid damage to the main
lymph duct. Body temperature was monitored and kept at 370
by adjusting the heat of the operating table.
Following completion of surgery rat plasma was administered
over 15 to 20 mm to replace estimated surgical losses. The
volume of plasma lost was estimated from the rise in hematocrit
between blood samples taken immediately after placement of
the arterial line and after finishing surgery. By assuming a blood
volume of 7% of body wt and constancy of erythrocyte volume,
plasma loss in milliliters was estimated as equaling 0.07 body
weight (Hct01 — Hctjnjtjal/Hctfiflal), where body weight is in
grams. Following surgical preparation, hematocrit rose from
42.2 0.2 to 48.4 0.2%. After administration of plasma,
hematocrit fell to a mean value of 46.1 0.3%, but it was not
restored to its initial value, suggesting that true plasma losses
may have been greater than estimated and that the protocol did
not result in volume expansion.
Four groups of rats were studied during reductions in arterial
pressure: (1) plasma-replaced control rats, (2) rats receiving
saralasin (Sarrenin, Röhm Pharma, West Germany) at a rate of
1 pg/kg mm, (3) rats injected with 2 mg/kg of indomethacin
followed by an infusion of 5 mg/kg hr, (4) hydropenic control
rats prepared as described above except that plasma was not
administered.
To identify distal and late proximal segments of the same
nephron, random proximal segments were punctured with 5 -
long-tipped glass capillaries containing stained Ringers solution
and connected to a manometer. This pipette was left in place
during both distal and proximal collections and was used to
control and maintain intratubular pressure during the collec-
tions. In all instances paired measurements of SNGFR from the
proximal and distal tubule of the same nephron were made.
Collections times were between 3 and 4 mm. Arterial pressure
was varied by tightening the aortic clamp. A new stable
pressure was achieved after about 5 mm of readjustments and
maintained for the time required to make fluid collections,
which was usually for about 35 to 45 mm. In each experiment
tubule fluid samples were collected at four different levels of
arterial pressure: at control pressure, between 95 and 100 mm
Hg, between 75 and 80 mm Hg, and at around 55 mm Hg. In
some experiments pressure varied sequentially downwards, in
others sequentially upwards. No effect of the direction of the
pressure change was detected, and in all instances results are
summarized together. At each of the three higher pressure
levels two to four distal and proximal sample pairs and one or
two timed urine collections were made. At the lowest pressure
level only proximal collections could be made.
In three additional saralasin-infused rats given plasma re-
placement, the tubuloglomerular feedback response to changes
in ioop of Henle flow rate was determined. Measurements were
made during a 1-hr control period and then during infusion of
saralasin at 1 g kg' min1. The microperfusion method has
been described previously [131. In brief, a mid or late proximal
tubule was blocked by placement of an immobile wax block,
and quantitative collections of early proximal tubular fluid were
made during perfusion of the ioop of Henle from a late proximal
site. In each tubule collections were made during perfusion at 0,
15, and 40 nI/mm.
Renin was measured in plasma samples taken at each arterial
pressure level in the control, hydropenic, and indomethacin-
treated animal groups using standard methods [14]. Prostaglan-
din excretion was measured in the indomethacin-treated rats
and three control rats. The method for determining urinary
PGE2 excretion has been described in detail earlier [15]. In
brief, PGE2 was extracted from acidified urine (pH 3.5) and
chromatographed on silicic acid columns to separate primary
prostaglandins. PGE2 was analyzed by radioimmunoassay using
sensitive and specific antisera. Antisera were produced in
rabbits by immunization with PG-thyroglobulin conjugates.
Tubular fluid volumes were determined by the transfer of the
sample to a constant bore capillary. The relative 3H-inulin
content of all tubular fluid, plasma and urine samples, was
determined with a scintillation counter (Beckman Instruments,
Fullerton, California). GFR for both single nephrons and whole
kidneys was determined as the product of flow rate and the
tubular fluid or urine to plasma inulin ratio. For the tubular fluid
samples, absorption up to the collection site was calculated as
SNGFR-V. For each pressure interval, for each experimental
animal the change in SNGFR, LSNGFR, and the change in
Fig. 1. Effect ofgraded reductions in arterial
pressure on SNGFR measured in the proximal
tubule (left panel, •, A) and distal tubule
(right panel, 0, A) in control, plasma-
replaced animals. Plotted points are animal
means (I, 0) and overall means SEM (A,
A).
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Table 1. Effect of stepwise reduction of arterial pressure on filtration rate and tubular fluid absorption in plasma-replaced control ratsa
Proximal measurements Distal measurements Whole kidney
UrineArterial
.
VEDpressure SNGFR Absorption SNGFR Absorption flow
mm Hg nI/mm TF/P1 nI/mm nI/mm TF/P10 ni/mm ni/mm N GFR ,al/min
114.6 40.8 1.74 16.8 31.8 3.85 8.8 22.5 7/23 915 12.4
±1.55 ±1.75 ±0.04 ±0.81 ±1.32 ±0.16 ±0.64 ±1.02 ±92 ±4.95
97.5 36.4 1.83 15.7 31.7 4.17 8.3 23.5 7/19 907 12.2
±0.81 ±2.18 ±0.08 ±1.19 ±1.6 ±0.25 ±0.7 ±1.29 ±70 ±3.86
78.0 31.0° 2.16° 16.4 29.3 5.32b 6.lb 23.2 7/20 902 55t
±0.37 ±1.56 ±0.1 ±1.22 ±1.48 ±0.4 ±0.49 ±1.24 ±43 ±1.49
56.0 18.0° 3.2° 11.4° — — — — 7/15 — —
±0.51 ±1.15 ±0.27 ±0.72
Values are means of all collections ± SE; N = number of rats/tubules.
b P < 0.05.
P < 0.001 (unpaired t test, compared to values at arterial pressure 114.6 mm Hg).
SNGFR per mm Hg, LSNGFR/LAP were calculated from the
mean SNGFR values.
All values are given ± SEM. The significance of changes in
SNGFR over each arterial pressure interval was determined by
paired t tests of the mean values for each animal; and compari-
son between proximal and distal collections were made by
performing paired t tests of values obtained in the same
nephron. To compare the four treatment groups analysis of
variance was performed; when the f test indicated significant
treatment effects, P values were determined by a modified t test
as described by Snedecor and Cochran [16].
Results
Control plasma-replaced rats
The effect of stepwise changes in arterial pressure on GFR in
control plasma-replaced animals is summarized in Tables 1 and
2 and Figure 1. Both whole kidney GFR and SNGFR measured
in the distal tubule (SNGFRdIt) did not change significantly
down to an arterial pressure of 78 mm Hg. In contrast SNGFR
measured in the proximal tubule (SNGFRPrOx) fell progressively
with decreasing arterial pressure. In the pressure step from 115
to 98 mm Hg the average decrease in SNGFRpr0x was 4.4 ± 0.77
nI min' or 0.26 ± 0.04 nl min per mm Hg. In the pressure
step from 98 to 78 the decrease averaged 5.3 ± 1.41 nl min or
0.26 ± 0.07 nl min mm Hg', all values being significantly
greater than zero. In the lowest pressure interval (78 to 55 mm
Hg) a steeper fall was noted, 12.9 ± 2.04 nl min or 0.60 ± 0.10
nl min' mm Hg. As shown in Figure 1, which depicts the
individual means of each experiment, the pattern of pressure
dependence of SNGFRpr0x and of pressure independence of
SNGFRdSt was reasonably uniform from experiment to
experiment.
A significant rise in (TF/P)1 measured in both the proximal
and the distal tubule was observed over the intermediate
pressure step but not over the upper pressure step. Total fluid
absorption measured at both proximal and distal nephrons sites
was essentially pressure-independent down to 78 mm Hg. An
apparent trend noted in the distal measurements of an associa-
tion between decreased pressure and increased absorption did
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115 to 95mm Hg
Control —0.3 0.51
(NS, —)
—0.1 1.4
(NS, NS)
—3.6 L32
(< 0.05, < 0.05)
—2.5 0.86
(< 0.05, NS)
—4.4 0.77
(< 0.01, —, < 0.01)
—4.9 1.35
(< 0.05, NS, < 0.01)
—8.7 1.88
(<0.001, NS, <0.05)
—5.6 0.81
(< 0.01, NS, < 0.05)
—0.26 0.04
(<0.001, —, <0.01)
—0.28 0.08
(<0.02, NS, <0.01)
—0.37 0.06
(< 0.01, NS, <0.05)
—0.26 0.04
(< 0.001, NS, <0.05)
95 to 77 mm Hg
Control
Saralasin
Indomethacin
Hydropenia
—2.5 1.14
(NS, —)
—4.7 0.81
(< 0.0!, < 0.05)
—8.5 1.48
(<0.01, <0.001)
—5.7 1.41
(< 0.02, < 0.05)
—5.3 1.41
(< 0.05, —, < 0.05)
—7.5 0.7!
(< 0.01, NS, < 0.05)
—9.2 0.57
(<0.001, <0.05, NS)
—7.3 1.43
(<0.01, NS, NS)
—0.13 0.06
(NS, —)
—0.26 0.04
(< 0.01, < 0.05)
—0.47 0.06
(< 0.01, < 0.005)
—0.3 0.07
(<0.02, <0.05)
—0.26 0.07
(< 0.05, —, NS)
—0.42 0.05
(< 0.01, NS, <0.05)
—0.57 0.05
(< 0.00!, < 0.05, NS)
—0.39 0.07
(<0.05, NS, NS)
77 to 55 mm Hg
Control
Saralasin
Indomethacin
Hydropenia
—12.9 2.'04
(< 0001, —)
—12.6 1.08
(<0.001, NS)
—11.9 1.72
(< 0.001, NS)
—11.4 1.46
(< 0.001, NS)
—0.60 0.10
(<0.01, —)
—0.62 0.03
(<0.001, NS)
—0.56 0.07
(<0.01, NS)
—0.60 0.08
(<0.00!, NS)
not reach statistical significance. In the lowest pressure interval
(78 to 55 mm Hg), together with the steeper fall in SNGFR,
proximal absorption fell markedly.
Saralasin-infused rats
Tables 2, 3, and 4 and Figure 2 summarize results obtained in
rats infused with saralasin at a rate of 1 g kg mm - . The
pressor effects of 20 ng of intravenously injected angiotensin II
were fully blocked by this dose of saralasin. As shown in Table
3, this dose was without effect on the tubuloglomerular feed-
back response to loop of Henle perfusion. Previous studies
demonstrating partial blockade of tubuloglomerular feedback
responses by saralasin used substantially higher doses [17, 18].
In saralasin-infused rats, SNGFRPrOX varied significantly with
arterial pressure over all three pressure steps. In the upper
pressure interval (113 to 96 mm Hg) whole kidney GFR and
SNGFRdIsIaI were virtually pressure independent. In the inter-
mediate pressure interval, however, both quantities became
pressure dependent. SNGFRd fell an average of 4.7 0.81 nl
min or 0.26 0.04 nl min mm Hg' when arterial pressure
was reduced from 96 to 77 mm Hg. This slope is significantly
greater than that observed in control animals in this pressure
Table 3. Effect of saralasin (I sgIkg mm) on the response of early
proximal flow rate (VEP) to loop of Henle perfusionu
Vp0 VEPI5 LVEp4o
ni/mm (N)
Control 27.7 2.1 —4.8 0.6 —12.9 1.3 (8)
Saralasin 27.5 1.1 —3.9 0.7 —11.9 0.9 (13)
Abbreviations: N, number of tubules; VEPO, the early proximal flow
rate measured without loop perfusion; VEpI5 and the change
in V produced by perfusion at 15 and 40 nI/mm.
Differences between control and saralasin were not significant.
interval. The pressure effects on urine flow and (TF/P)1 were
similar to those observed in control rats.
Indomethacin-treated rats
Results from experiments in which indomethacin was given
are summarized in Figure 3 and Tables 5 and 2. To verify that
indomethacin blocks prostaglandin synthesis under the condi-
tions of these studies, urinary excretion rates of PGE2 were
measured. In control rats, PGE2 excretion averaged 94.1
Table 2. Summary of all studies: change in SNGFR (SNGFR) and change in SNGFR per mm Hg change in arterial pressure (SNGFR/AP)
under the experimental conditions testeda
SNGFRdI
nlmin SNGFRproxnimin
ASNGFR
AAP
niminmtnHg'
.dist SNGFR
zIAP
niminmmHg
prox
Saralasin
Indomethacin
Hydropenia
—0.01 0.03
(NS, —)
—0.01 0.05
(NS, NS)
—0.15 0.04
(< 0.02, NS)
—0.12 0.04
(<0.05, NS)
a Data are the means of values calculated for each experiment. Where applicable P values were calculated for three comparisons. The first P
value is the probability that the observed change is equal to zero and was determined by a paired t test. The second P value is the probability that
the observed value is equal to the control value for the same pressure interval and collection site and was determined by a modified t test where
analysis of variance indicated significant treatment effects [151. For proximal values in the upper two pressure intervals a third P value, the
probability that the observed change is equal to that determined under the same conditions (treatment and pressure interval) in the distal tubule, is
also given. These P values were calculated by a paired t test.
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Fig. 2. Effect of graded reductions in arterial
pressure on SNGFR in animals in which
saralasin (1 p.g kg min) was infused.
Symbols are the same as those used in Figure 1.
Mean arterial BP
Table 4. Effect of stepwise reduction in arterial pressure on filtration rate and tubule fluid absorption in saralasin-infused rats
Arterial
pressure
mm Hg
Prox
SNGFR
imal measur
TF/Ph,
ements
Absorption SNGFR
Distal me
TF/P1,,
asurements
VED Absorption
N
W
GFR
hole kidney
Urine flow
nI/mm nI/mm nI/mm nI/mm ni/mm j.d/min
113.0 41.6 1.70 16.7 32.0 4.11 8.2 23.8 6/24 l051 9.7
±2.54 ±1.17 ±0.05 ±0.84 ±1.02 ±0.23 ±0.43 ±0.82 ±36 ±2.06
95.5 35.8k 1.80 l5.3 30.7 4.16 7.7 23.0 7/19 996 4.7
±0.79 ±1.65 ±0.07 ±1.18 ±1.58 ±0.22 ±0.49 ±1.31 ±40 ±1.65
77.0 28.la 2.l8c 14.5 26.0c 5.46b 5.2" 20.8b 7/20 809b 1.9"
±0.35 ±1.17 ±0.12 ±1.09 ±1.19 ±0.39 ±0.3 ±1.1 ±60 ±0.32
56.5 17.6a 4.65c 135b — — — 5/9 — —
±1.0 ±1.52 ±0.48 ±1.26
a Values are means of all collections ± SE; N, number of rats/tubules.
b P < 0.05.
P < 0.001 (unpaired t test, compared to values at arterial pressure 113 mm Hg).
62.1, 81.3 ± 57.5, and 29.6 ± 4.8 pg min' at arterial pressures
of 115, 95, and 78 mm Hg. After indomethacin treatment, PGE2
excretion was reduced to 14.9 ± 1.9, 2.5 ± 0.77, and 2.2 ± 1.06
pg min at the three pressure levels. Indomethacin blunted the
rise in plasma renin that occurred with decreased arterial
pressure (Table 6).
Indomethacin significantly increased the pressure dependen-
cy of the filtration rate. At an arterial pressure of 77 mm Hg,
whole kidney GFR was approximately half the control value at
an arterial pressure of 119 mm Hg. The average decrease in
distal SNGFR was 3.6 ± 1.32 nl min or 0.15 ± 0.04 nI min
mm Hg' in the upper pressure interval (119 to 95 mm Hg) and
8.5 ± 1.48 nI min or 0.47 ± 0.06 nI min1 mm Hg1 in the
intermediate pressure interval (95 to 78 mm Hg). Both slopes
were significantly greater than those observed in control ani-
mals. The pressure dependency Of SNGFRpr0x in the intermedi-
ate pressure interval was also significantly greater than in
control animals. Proximal and distal (TF/P)1 increased signifi-
cantly with both pressure steps.
Hydropenic rats
The results obtained in hydropenic animals are summarized
in Tables 7 and 2 and in Figure 4. These rats differed from
controls only in that they did not receive plasma to replace
estimated surgical losses. The resulting modest degree of vol-
ume contraction was associated with a significant increase in
the pressure dependency of filtration rate. SNGFRd,, which in
control rats was independent of arterial pressure, fell signifi-
cantly over both pressure intervals. The decrease averaged 2.5
± 0.86 nI min1 or 0.12 ± 0.04 nI min' mm Hg_I between 118
and 95 mm Hg and 5.7 ± 1.41 nl min' or 0.30 ± 0.07 nI min'
mm Hg' between 95 and 77 mm Hg. Whole kidney GFR was
also more pressure dependent than in control animals. In
association with a declining filtration rate, decrements in total
fluid reabsorption were seen. Control pressure plasma renin
levels were higher than in plasma-replaced animals, as shown in
Table 6.
Quantitative assessment of system contributions
To compare the effectiveness of autoregulation of nephron
filtration rate under the conditions of the four protocols, we
have estimated magnification for each state. Magnification is an
index of homeostatic effectiveness defined as the ratio of the
change in a variable. It is produced by a given perturbation to
the change in that variable that the same perturbation would
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Fig. 3. Effect of graded reductions in arterial
pressure on SNGFR in animals to which
indomethacin was administered (2 mg/kg
prime followed by 5 mg kg hr). Symbols
are the same as those used in Figure 1.
Table 5. Effect of stepwise reduction in arterial pressure on filtration rate and tubule fluid absorption in indomethacin-treated rats'
Arterial
pressure
Proximal measurements Distal measurements Whole kidney
SNGFR Absorption SNGFR
.
VED Absorption GFR Urine flows
mm Hg ni/mm TF/P10 nl/min ni/mm TF/P10 nI/mm ni/mm N pi/min
119.0 44.8 1.90 20.0 38.6 4.18 9.5 29.1 5/17 1120 12.6
±2.48 ±1.95 ±0.09 ±1.23 ±1.4 ±0.16 ±0.54 ±1.07 ±97 ±2.7
95.0 36.7b 2.37' 20.6 34.0' 5.94' 6.2' 27.8 6/16 909 9.0
±1.11 ±1.57 ±0.1 ±0.75 ±1.68 ±0.39 ±0.61 ±1.32 ±169 ±3.5
77.5 26.9' 3.01° 17.5 25.5' 16.19' 2.3° 23.2' 6/15 624b II'
±0.0 ±1.34 ±0.24 ±1.22 ±1.29 ±3.3 ±0.37 ±1.26 ±118 ±0.26
56.5 15.2° 5.61c 12.3' — — — — 5/9 — —
±0.61 ±0.46 ±0.57 ±0.46
Values are means of all collections ± s; N, number of rats/tubules.
b P < 0.05.
P < 0.001 (unpaired t test, compared to values at arterial pressure 119 mm Hg).
Table 6. Effect of reduced arterial pressure on plasma renin concentration (ng angiotensin I/mi hr) in control plasma-replaced, indomethacin-
treated, and hydropenic rats'
Arterial p ressure, mm Hg
1 15 95 78 55 N
Control 8.5 ± 1.14 18.2 ± 35h 45.3 ± 9.7° 156.9 ± 35.8' 6
Indomethacin 6.6 ± 1.99 10.0 ± 6.9 19.0 ± 2.41bd 56.1 ± 12.2" 5
Hydropenia 29.4 ± 4.3° 41.4 ± l5.5' 92.1 ± 45.0 172.6 ± 15.0" 3
'Values are means ± SE; N, number of rats.
P < 0.05, P < 0.005 (compared to value at 115 mm Hg).
d P < 0.05, P < 0.005 (compared to control).
produce in the absence of all control mechanisms. In the
present case, it can be defined as:
dSNGFRI dAPeontroiMagnification =
dSNGFRJ dAPO control
Moore [191 has recently drawn attention to the advantages of
this index of autoregulatory effectiveness. Magnification is
related to another control theory index, the open loop gain, by
the relationship: open loop gain = (1/magnification) — 1 [20].
One minus the magnification is the fractional compensation; a
magnification of 0.02 corresponds to a situation where control
mechanisms compensate for 98% of the perturbation. The
contribution of an individual regulatory mechanism can be
assessed by comparing the magnification before and after its
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Fig. 4. Effect of graded reductions in arterial
pressure on SNGFR in hydropenic animals.
Symbols are the same as those used in Figure 1.
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Table 7. Effect of stepwise reduction in arterial pressure on filtration rate and tubule fluid absorption in hydropenic rats"
Arterial
pressure
Proximal measurements Distal measurements GFR Urifle flow
SNGFR Absorption SNGFR VED Absorption
-_____________________
mm Hg ni/mm TF/P1 ni/mm ni/mm TF/P1,, ni/mm ni/mm N
-
1u1/min
117.5 41.0 1.95 19.8 34.5 4.72 7.6 26.8 5/15 1259 5.7
±1.3 ±1.69 ±0.03 ±0.72 ±1.24 ±0.25 ±0.53 ±0.97 ±75 ±1.9
95.2 34.0' 2.28" 18.9 31.5 557b 59b 26.0 5/13 1155 3.1
±0.16 ±1.32 ±0.07 ±0.8 ±1.08 ±0.3 ±0.5 ±0.99 ±42 ±0.5
76.7 27.1" 2.72" 16.6b 25.9" 10.96" 2.9" 23.Ob 5/14 938b 1.45
±0.27 ±1.18 ±0.14 ±0.69 ±0.95 ±1.22 ±0.39 ±0.71 ±24 ±0.25
57.5 15.7 435c 11.6" — — — — 5/10 — —
±0.0 ±0.48 ±0.38 ±0.48
Values are means of all collections ± sa; N, number of rats/tubules.
b P < 0.05.
"P < 0.001 (unpaired t test, compared to values at arterial pressure of 117.5 mm Hg).
blockade. If the magnification rises from 0.02 to 0.5 with the
blockade of a potential control mechanism, that mechanism can
be said to be responsible for 48% compensation.
We have taken the measured values for the changes in
SNGFR per mm Hg over each pressure interval as an estimate
of the slope in the numerator and the measured slope in the
subautoregulatory range as an estimate of the passive or no-
control slope in the denominator. Values were calculated for
each animal for each pressure interval from the mean of
SNGFR determinations at each pressure level.
In the pressure interval 115 to 95 mm Hg, with all mecha-
nisms intact, autoregulation compensates for 98% (magnifica-
tion 0.02 ± 0.08, Table 8) of the predicted passive change in
SNGFR and in the pressure interval 95 to 78 mm Hg for 76%
(magnification 0.24 ± 0.09). In the 115 to 95 mm Hg pressure
step, the blockade of distal delivery results in approximately a
50% reduction in autoregulatory effectiveness (magnification
rises from 0.02 ± 0.08 to 0.50 ± 0.10) and interference with PG
synthesis in approximately a 30% reduction (magnification 0.3
± 0.1). The angiotensin receptor blockade is without effect. In
the lower pressure interval, 95 to 78 mm Hg, the blockade of
tubuloglomerular feedback diminishes autoregulatory compen-
sation by approximately 30% (magnification from 0.24 ± 0.09 to
0.54 ± 0.2), and angiotensin II receptor blockade similarly
reduces it by about 20% (magnification, 0.43 ± 0.08). In
contrast, in this pressure interval a very substantial proportion
of autoregulatory compensation appears to depend on intact PG
synthesis, since indomethacin reduces autoregulatory compen-
sations by approximately 60% (magnification 0.87 ± 0.13).
Discussion
Autoregulation, the capacity of the renal vasculature to
maintain blood flow and filtration rate almost constant when
arterial pressure changes, is a phenomenon that has been
extensively investigated. Nonetheless, there is no unanimity
about the mechanisms responsible for this response. One cause
for the lack of agreement has been the search for a unitary
explanation. It becomes increasingly clear that no single regula-
tory mechanism can completely explain autoregulation of renal
vascular resistance. In previous studies we examined the partic-
ipation of the tubuloglomerular feedback mechanism in autoreg-
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ulatory adjustments in the supra-normal pressure range. We
found that, although an intact tubuloglomerular feedback mech-
anism was necessary for constancy of filtration rate with rising
arterial pressure, it could not explain more than about one half
of the steady-state regulatory response [5].
The present studies examine autoregulation in the subnormal
pressure range. Autoregulation of blood flow requires vasodila-
tation when arterial pressure falls, Filtration rate autoregulation
is probably generally a consequence of the changes in resist-
ance that maintain blood flow. Nevertheless, over a limited
flow range, changes in postglomerular resistance in the opposite
direction, that is, vasoconstriction with falling arterial pressure,
may contribute to constancy of filtration rate at the expense of
blood flow, Decreasing arterial pressure into the subnormal
range has been observed to produce a dissociation between
filtration rate and blood flow autoregulation [II]. Afferent
resistance has been found to decrease and efferent resistance to
increase 1211', The present studies examine three mechanisms
which may participate in producing these resistance changes.
The mechanisms studied are tubuloglomerular feedback, the
renin-angiotensin system, and prostaglandins. In the present
experiments the pressure dependency of filtration rate with all
mechanisms intact and during their separate and combined
blockade was measured.
These studies were performed in rats given plasma to replace
estimated surgical losses and thus produce an approximately
euvolemic state. Previous investigators have observed that in
the rat autoregulation of both blood flow 123] and SNGFR [21]
is relatively inefficient below arterial pressures of about 100mm
Hg. In a group of rats in which surgical losses were not
replaced, we also observed that GFR was strongly pressure-
dependent below 95 to 100 mm Hg. However, plasma replace-
ment resulted in a preparation in which whole kidney and single
nephron GFR were almost pressure-independent down to about
80 mm Hg. The mechanisms responsible for this shift were not
investigated in the present study. One may speculate, however,
that the efficiency of autoregulation depends on the unopposed
action of local regulatory mechanisms. Plasma volume constric-
tion may increase sympathetic tone and possibly activate other
vasoconstrictor systems which may oppose full expression of
autoregulatory compensation.
The measurements made in the present studies yield values
for the slope or the change in SNGFR per millimeters of
mercury for each of three pressure intervals under varying
conditions. To arrive at quantitative estimates of the participa-
tion of the separate mechanisms in GFR autoregulation, it is
necessary to have for comparison an estimate of the passive
slope or the change in SNGFR per mm Hg that would occur
with constant afferent and effererit resistance. The measured
change in SNGFR in the subautoregulatory range provides one
estimate of this quantity. It has been observed that total renal
vascular resistance is virtually constant in the subautoregula-
tory range [21, 23]. In the present studies SNGFR fell an
'Decreases in the ultrafiltration coefficient have also been measured
following decreases in arterial pressure in this pressure range 1221;
however, this 'anti-autoregulatory' response is likely to be without
substantial impact on filtration rate, because filtration pressures proba-
bly reach equilibrium under these conditions.
average of 0.60 nI/mm per mm Hg when arterial pressure was
decreased from 78 to 55 mm Hg. This value falls within the
range of theoretical estimates of the passive slope [5, 24—261. It
was not influenced by any of our experimental manipulations,
further suggesting that little regulation occurs in this pressure
interval. We have used this value as an estimate of the passive
slope; although only an approximation, it provides a useful
index for comparison. Figures 5A and B summarize the effect of
blockade of the individual mechanisms on the measured
SNGFR-pressure slope. Shown for comparison by the upper
dotted line is the slope measured with all mechanisms intact and
by the lower dotted line the subautoregulatory slope, taken as
an estimate of the no-compensation slope. The slope values are
also used to calculate magnification values which permit quanti-
tative estimates of the fractional contribution of the individual
mechanisms.
Tubu/oglomerular feedback. The contribution of the tubulo-
glomerular feedback mechanism was assessed by interrupting
flow to the distal nephron and measuring SNGFR in the
proximal tubule. SNGFR autoregulation was consistently poor-
er when distal flow was interrupted. Values obtained were in
approximate agreement with most previous reports ([2—5, 27];
for summary see 128]). For example, in a similarly designed
study Robertson et al [21] reported a change of proximal
SNGFR of —0.18 nI/mm per mm Hg in plasma-loaded rats as
compared to the value of —0.26 in our plasma-replaced rats.
Also, the change of —0.18 nI/mm per mm Hg reported by
Maddox, Troy, and Brenner [27] for uninephrectomized vol-
ume-expanded rats is similar to the value of —0.26 found in this
study for the same pressure decrement.
It is highly probable that the effect of distal flow on GFR is
equivalent to the tubuloglomerular feedback phenomenon dem-
onstrated by single nephron loop perfusion [29]. The participa-
tion of tubuloglomerular feedback in GFR autoregulation in the
subnormal pressure range is consistent with recent microperfu-
sion results from this laboratory. When loop of Henle flow rate
[10] or early distal chloride concentration [30] is varied, the
resulting changes in SNGFR show a sigmoidal pattern. In our
laboratory the normal free flow value of distal flow rate and
SNGFR, the operating point, lies on the steepest portion of the
sigmoidal curve [10]; thus, both increases and decreases in
distal delivery are expected to affect SNGFR inversely. As
would be predicted from the sigmoidal relationship, a greater
contribution of distal delivery was apparent in the first pressure
interval from normal downwards (115 to 95 mm Hg) than in the
lower pressure step (95 to 78 mm Hg). Based on the magnifica-
tion calculations, we estimate that tubuloglomerular feedback
produces 48% autoregulatory compensation in the upper pres-
sure interval and 30% in the lower interval. Under certain
experimental circumstances, the operating point may be on the
upper shoulder of the sigmoidal curve [31]. In this case changes
in distal delivery should only induce increases and not de-
creases in renal resistance, and the tubuloglomerular feedback
mechanism would not be predicted to contribute to autoregula-
tion of SNGFR in the subnormal pressure range. In fact, a poor
autoregulatory capacity in the subnormal pressure range has
been reported by laboratories observing a high threshold for the
responses to loop perfusion [32].
In the normal pressure range, with all mechanisms intact,
GFR is virtually constant when pressure changes. A question
not resolved by our present data is the nature of the error signal
U-(3z(1)
<1
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Fig. 5. Effect of separate and combined blockade of autoregulatory mechanisms on the measured autoregulatory slope (SNGFRIMP). Values
from control, saralasin, and indomethacin-treated animals are plotted. Open (0) and closed (•) circles represent values measured with intact and
interrupted distal flow, respectively. Shown for comparison by the upper dotted line is the autoregulatory slope measured with all mechanisms
intact and by the lower dotted line the slope measured in the subautoregulatory range. The subautoregulatory slope provides an estimate of the
passive or no-control slope. Because of the uncertainties in this assumption, the contribution of residual mechanisms must be viewed as only
approximate.
Table 8. Magnification of the autoregulatory control systema
Pressure change, mm Hg
115.0 — 95.0 95.0 — 78.0
Control
Distal 0.02 0.08 0.24 0.09
Proximal 0.5 0.1 0.54 0.2
Saralasin
Distal 0.01 0.16 0.43 0.08
Proximal 0.46 0.13 0.68 0.08
Ihdomethacin
Distal 0.3 0.1 0.87 0.13
Proximal 0.67 0.12 1.03 0.08
Hydropenia
Distal 0.22 0.07 0.58 0.19
Proximal 0.47 0.1 0.75 0.23
Values are means of experimental means SE.
to the feedback mechanism that maintains vasodilatation in the
absence of changes in GFR. Two possibilities would seem
worthy of consideration. An error signal may be generated if
arterial pressure affects absorption proximal to the macula
densa. In our studies both fractional and absolute absorption
tended to increase and early distal flow tended to decrease as
arterial pressure fell, even when GFR remained constant.
Corresponding small decreases in proximal fluid absorption at
constant GFR were previously found in response to an increase
in arterial pressure [5]. These changes in absorption were,
however, marginal and may not be sufficiently large to provide
an error signal. An alternative mechanism may be a resetting of
the feedback mechanism. One has to postulate that a signal of
the same magnitude produces a diminished resistance change.
Whether acute decrements in arterial pressure cause such a
change in feedback sensitivity is unclear.
The results suggest that the tubuloglomerular feedback mech-
anism alone cannot produce full autoregulatory compensation.
When distal delivery was interrupted, the SNGFR-pressure
slope was —0.26 nI/mm per mm Hg over both pressure inter-
vals. This value differs substantially from the value, —0.6 nI/mm
release has been shown to be a highly nonlinear function of
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per mm Hg, measured in the subautoregulatory range, which
we take as an estimate of the no-compensation slope. Although
this value can only be considered an approximation, it seems
safe to conclude that residual mechanisms are needed to
account for the observed autoregulatory effectiveness after
distal blockade.
Renin-angiotensin. In the present studies infusion of sarala-
sin impaired autoregulation of SNGFR, but its effect was
limited to the pressure interval at the lower end of the autoregu-
latory range, 95 to 78 mm Hg. In this interval, the magnification
estimates suggest that the renin-angiotensin system contributes
approximately 20% to autoregulatory compensation. These
findings are consistent with previous studies of Hall et al [111
and Kirchheim et al [12] in the dog demonstrating that saralasin
impaired subnormal pressure range autoregulation in this spe-
cies as well. It is not unexpected that the blockade of angioten-
sin has the greatest effect at lower arterial pressures, since renin
arterial pressure, with the most marked increases noted below
100 mm Hg [12, 33, 341.
The effect of saralasin cannot be attributed to its attenuating
effect on tubuloglomerular feedback. Angiotensin analogues do
diminish the response of SNGFR to loop perfusion but only at
much higher doses than used in the present studies [17, 181.
Stowe, Schnermann, and Hermle [17] observed tubuloglomer-
ular feedback blockade with doses of angiotensin analogues of 5
to 30 rg/kg mm, while Ploth and Roy [181 demonstrated the
same effect with 20 pg/kg mm of saralasin. The dose used in
the present studies, I pg/kg mm, was sufficient to prevent the
pressor action of intravenous angiotensin II but had no measur-
able effect on the tubuloglomerular response to loop perfusion.
Furthermore, saralasin did not influence the effect of distal
blockade on autoregulatory effectiveness. The magnification
calculations yield virtually identical estimates for the fractional
contribution of tubuloglomerular feedback in saralasin-treated
animals as in control animals (45% vs. 48% for the 115 to 95 mm
Hg pressure step and 35% vs. 30% for the 95 to 78 mm Hg
pressure step). Thus, our data suggest that saralasin influences
autoregulation through a mechanism independent of tubulo-
glomerular feedback.
It is more likely that the effect of saralasin is due to the
blockade of angiotensin H effects on the efferent arteriole.
Angiotensin has both filtration-rate preserving effects (in-
creased glomerular capillary pressure due to constriction of the
efferent arteriole) and filtration-rate-impairing effects (dimin-
ished glomerular filtration coefficient and afferent arteriolar
constriction) [35—37]; the effect of saralasin may depend on the
balance that prevails under the exact experimental condition
studied. With a number of protocols, the blockade of angioten-
sin has not measurably impaired autoregulation [38—40].
Prostag/andins. Perhaps the most unexpected result of our
study is the dramatic effect of indomethacin on autoregulation
of SNGFR. We found GFR to be highly pressure-dependent in
indomethacin-treated animals. Our results suggest that prosta-
glandin-dependent adjustments produce 28% autoregulatory
compensation in the 115 to 95 mm Hg pressure step and 63% in
the 95 to 78 mm Hg pressure interval. In early studies in isolated
dog kidney, it was also observed that indomethacin diminished
autoregulatory efficiency [41]. Recent reports, however, have
not demonstrated an effect of impaired prostaglandin synthesis
on autoregulation [39, 42—44]. Although this discrepancy cannot
be resolved completely, a number of factors make previous
reports not comparable with the present studies. Most previous
studies have used dogs rather than rats [39, 41, 42, 44] or
measured only blood flow and not filtration rate [41—43]. In
hydropenic rats no effect of either indomethacin or meclofena-
mate on blood flow autoregulation was detected [43]. However,
since autoregulation in the subnormal pressure range is not
pronounced in hydropenic rats, an impairment produced by an
experimental protocol might not be detectable. Furthermore,
blood flow and filtration rate autoregulation cannot necessarily
be assumed to be parallel as demonstrated in the studies of Hall
et al [11] with saralasin infusion. There is no previous study of
filtration rate autoregulation in the rat.
Diminished autoregulatory effectiveness probably partially
reflects diminished responsiveness of the tubuloglomerular
feedback mechanism. Administration of indomethacin has been
shown to blunt the feedback response to loop perfusion [45, 46].
The magnification calculations suggest that the tubuloglomer-
ular feedback contribution is reduced in indomethacin-treated
animals (37% vs. 48% in the 115 to 95 mm Hg pressure interval
and 13% vs. 20% in the 95 to 78 mm Hg interval). The effect of
indomethacin cannot, however, be explained fully by blunting
of the tubuloglomerular feedback mechanism. In the lower
pressure interval the impairment of autoregulation produced by
indomethacin is too large to be explained by interference with
tubuloglomerular feedback, so an effect of indomethacin on the
residual mechanisms must be postulated. During the combined
blockade of distal delivery and prostaglandin synthesis, the
observed SNGFR-pressure slope in the lower pressure interval,
—0.57 nI/mm per mm Hg, approached our estimate of the no-
compensation slope, —0.60 nI/mm per mm. Prostaglandins have
also been shown to participate in the control of renin secretion.
The reduction in renin secretion that follows indomethacin
administration, and the consequent reduced rate of angiotensin
II formation may contribute to the impairment of autoregulation
in this pressure range. Additional independent prostaglandin
effects are also likely.
Summary. Results of the present studies suggest that mainte-
nance of filtration rate in the face of falling arterial pressure
requires the coordinate action of several mechanisms. In euvo-
lemic rats, in which filtration rate was almost constant down to
an arterial pressure of 80 mm Hg, the tubuloglomerular feed-
back mechanism was found to be important at or close to
normal arterial pressure, but to have a diminishing role as
pressure was reduced to the lower limit of the autoregulatory
range. Tubuloglomerular feedback-mediated adjustments were
not sufficient alone to account for the observed autoregulatory
effectiveness. The residual mechanisms appear to include a
modest contribution of the renin angiotensin system at lower
arterial pressures. Interference with prostaglandin synthesis
markedly impaired autoregulation, especially at the lower end
of the autoregulatory range, suggesting that an intact prosta-
glandin system is also necessary for filtration rate maintenance
in this pressure range.
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